These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31951166)

  • 1. Carbazole Derivatives as Kinase-Targeting Inhibitors for Cancer Treatment.
    Ceramella J; Iacopetta D; Barbarossa A; Caruso A; Grande F; Bonomo MG; Mariconda A; Longo P; Carmela S; Sinicropi MS
    Mini Rev Med Chem; 2020; 20(6):444-465. PubMed ID: 31951166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor carbazoles.
    Asche C; Demeunynck M
    Anticancer Agents Med Chem; 2007 Mar; 7(2):247-67. PubMed ID: 17348830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebeccamycin derivatives as dual DNA-damaging agents and potent checkpoint kinase 1 inhibitors.
    Marminon C; Anizon F; Moreau P; Pfeiffer B; Pierré A; Golsteyn RM; Peixoto P; Hildebrand MP; David-Cordonnier MH; Lozach O; Meijer L; Prudhomme M
    Mol Pharmacol; 2008 Dec; 74(6):1620-9. PubMed ID: 18768386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbazole scaffolds in cancer therapy: a review from 2012 to 2018.
    Issa S; Prandina A; Bedel N; Rongved P; Yous S; Le Borgne M; Bouaziz Z
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1321-1346. PubMed ID: 31328585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review.
    Kwiecień H; Goszczyńska A; Rokosz P
    Curr Pharm Des; 2016; 22(7):879-94. PubMed ID: 26648467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of 5-substituted 9-hydroxypyrrolo[3,4-c]carbazole-1,3(2H,6H)-diones as check point 1 kinase inhibitors.
    Sako Y; Ichikawa S; Osada A; Matsuda A
    Bioorg Med Chem; 2010 Nov; 18(22):7878-89. PubMed ID: 20943405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
    Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promising Targets in Anti-cancer Drug Development: Recent Updates.
    Kumar B; Singh S; Skvortsova I; Kumar V
    Curr Med Chem; 2017; 24(42):4729-4752. PubMed ID: 28393696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinnamic Acid Derivatives as Inhibitors of Oncogenic Protein Kinases--Structure, Mechanisms and Biomedical Effects.
    Mielecki M; Lesyng B
    Curr Med Chem; 2016; 23(10):954-82. PubMed ID: 26980568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Kinase-Bromodomain Inhibitors in Anticancer Drug Discovery: A Structural and Pharmacological Perspective.
    Carlino L; Rastelli G
    J Med Chem; 2016 Oct; 59(20):9305-9320. PubMed ID: 27559828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase inhibitory potencies and in vitro antiproliferative activities of N-10 substituted pyrrolo[2,3-a]carbazole derivatives.
    Akué-Gédu R; Letribot B; Saugues E; Debiton E; Anizon F; Moreau P
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3807-9. PubMed ID: 22543026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrrolocarbazoles as checkpoint 1 kinase inhibitors.
    Hénon H; Conchon E; Hugon B; Messaoudi S; Golsteyn RM; Prudhomme M
    Anticancer Agents Med Chem; 2008 Aug; 8(6):577-97. PubMed ID: 18690823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indolinones as promising scaffold as kinase inhibitors: a review.
    Prakash CR; Raja S
    Mini Rev Med Chem; 2012 Feb; 12(2):98-119. PubMed ID: 22372601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potential Targets and Mechanisms of a Carbazole and Pyrazole Containing Anticancer Compound.
    Xie J; Gore JC
    Curr Cancer Drug Targets; 2020; 20(5):364-371. PubMed ID: 31951182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin.
    Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA
    Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspective of natural alkaloid carbazole and its derivatives as antitumor agents.
    Shaikh MS; Karpoormath R; Thapliyal N; Rane RA; Palkar MB; Faya AM; Patel HM; Alwan WS; Jain K; Hampannavar GA
    Anticancer Agents Med Chem; 2015; 15(8):1049-65. PubMed ID: 25584693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinases as targets for anticancer agents: from inhibitors to useful drugs.
    Fabbro D; Ruetz S; Buchdunger E; Cowan-Jacob SW; Fendrich G; Liebetanz J; Mestan J; O'Reilly T; Traxler P; Chaudhuri B; Fretz H; Zimmermann J; Meyer T; Caravatti G; Furet P; Manley PW
    Pharmacol Ther; 2002; 93(2-3):79-98. PubMed ID: 12191602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule kinase inhibitors as anti-cancer therapeutics.
    Chahrour O; Cairns D; Omran Z
    Mini Rev Med Chem; 2012 May; 12(5):399-411. PubMed ID: 22303944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy.
    Soltan OM; Shoman ME; Abdel-Aziz SA; Narumi A; Konno H; Abdel-Aziz M
    Eur J Med Chem; 2021 Dec; 225():113768. PubMed ID: 34450497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton's tyrosine kinase (BTK) and Janus kinase 2 (JAK2).
    Liu Q; Batt DG; Lippy JS; Surti N; Tebben AJ; Muckelbauer JK; Chen L; An Y; Chang C; Pokross M; Yang Z; Wang H; Burke JR; Carter PH; Tino JA
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4265-9. PubMed ID: 26320619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.